BioUK Life Science Registry

Member list of BioUK

Below you find a list of all members of BioUK in alphabetical order.
Results 121 - 140 out of 523 displayed
Concept Life Sciences

Frith Knoll Road
High Peak
Chapel-en-le-Frith, SK23 0PG
United Kingdom

Main sector:

Biotechnology - R&D Services

Subsector:

Analytical services, CMO (Contract Manufacturing Organization), CRO (Contract Research Organization), Proteomics, Screening, Synthesis services

Indications:

Neoplasms / cancer / oncology, Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology, Diseases of the nervous system / neurology

Description:

Concept Life Sciences is a contract research and manufacturing organization. The company offers a comprehensive range of discovery and development services and analytical solutions across the pharmaceutical, biotechnology, agrochemical, and food sectors. The company's services include Assay Development & Screening, Process Research & Development, In vitro ADME & DMPK, In vivo/Ex vivo Toxicology, etc.

ConserV Bioscience Limited

Camp Road
Heyford Park Innovation Centre, 77 Heyford Park, Oxfordshire
Bicester, OX25 5HD
United Kingdom

Main sector:

Biotechnology - Therapeutics and Diagnostics

Subsector:

Anti-infectives, Vaccines

Indications:

Infectious and parasitic diseases / infectiology / parasitology, Respiratory / pulmonology

Products:
In development: 8
Employees:
At this location: 2
Worldwide: 2
Description:

ConserV Bioscience Limited is a clinical-stage biotechnology company focused on developing vaccines that provide broad protection against endemic and emerging infectious diseases. The company uses a proprietary in silico antigen-discovery platform to identify conserved regions of viral proteins that contain clusters of T-cell epitopes with broad HLA coverage. ConserV Bioscience vaccine approach targets highly conserved viral antigens to generate durable immune responses against rapidly mutating viruses. ConserV is advancing a pipeline of vaccine candidates addressing multiple infectious diseases, including influenza, coronavirus, mosquito-borne viruses, HIV, hepatitis C, hepatitis B, rotavirus, and Chagas disease. The company’s lead programs include a broad-spectrum influenza vaccine and a mosquito-saliva-based vaccine designed to protect against multiple mosquito-borne pathogens. ConserV is also developing the pan-coronavirus vaccine candidate UNICOR-v, aimed at providing protection against diverse coronavirus strains.

Cormica Ltd

12-18 Grosvenor Gardens, 5th Floor
London, SW1W 0DH
United Kingdom

Main sector:

Biotechnology - R&D Services

Subsector:

Analytical services

Description:

Cormica is a provider of testing services for medical device and pharmaceutical manufacturers, drawing on the expertise and heritage of its world renowned laboratories. The company offer a broad range of testing services, including medical device testing, analytical chemistry, microbiology testing, physical product testing, and packaging testing.

Cortex Organics Ltd.

Centre for Innovation and Enterprise, Begbroke Science Park
Oxford, OX5 1PF
United Kingdom

Main sector:

Biotechnology - R&D Services

Subsector:

CMO (Contract Manufacturing Organization), Synthesis services

Description:

Cortex Organics Ltd. is a company providing synthetic chemistry services for pharmaceutical and agrochemical research and development. The company offers medicinal chemistry, route scouting, custom synthesis, natural product and 3D scaffold synthesis, stable isotope labelling and analytical services, as well as specialized reagents and building blocks for organic synthesis.

Coulter Partners

83 Clerkenwell Rd
Skipper Building, First Floor
London, EC1R 5AR
United Kingdom

Main sector:

Professional Services and Consulting

Subsector:

Business development, Human resources services, Management consulting

Description:

Coulter Partners provides leadership consultancy to life sciences, health and technology innovation businesses globally. The company's mission is to strongly impact value and growth. The company works across all areas of the life science sector - from pharmaceutical and biotech companies to academic/research institutes.

Creasallis Ltd

Milton Road
25 Bio-Innovation Centre, Cambridge Science Park, Cambridgeshire
Cambridge,
United Kingdom

Main sector:

Biotechnology - R&D Services

Subsector:

Drug delivery, Proteomics

Description:

Creasallis Ltd is a biotechnology company specializing in novel protein engineering solutions for antibody-based therapeutics. They aim to improve the delivery of antibody drugs, particularly into solid tumors. The company focuses on developing innovative antibody engineering solutions, including their flagship technology, CreaTap. CreaTap is the patented Creasallis Tumor Antibody Penetration technology that enhances the penetration of antibody-based drugs into tumors.

Creative Biolabs

17 Ramsey Road
Shirley, 11967
USA

Main sector:

Biotechnology - R&D Services

Subsector:

Analytical services, Cell culture, Genomics, Proteomics, Synthesis services

Description:

Creative Biolabs is specialized in providing custom biotechnology and pharmaceutical services that cover the full scope of biotechnology needs of early drug discovery and drug development. The company also conducts in depth antibody humanization and affinity maturation using phage display and DNA mutagenesis approaches.
The company's service portfolio includes mouse and rat monoclonal antibody production using hybridoma technology, human, monkey, rabbit, chicken, dog, llama and camel monoclonal antibody production using various antibody library technologies.

Crucible Therapeutics Ltd.

The Innovation Centre, 217 Portobello
Sheffield, S14DP
United Kingdom

Main sector:

Biotechnology - Therapeutics and Diagnostics

Subsector:

Gene therapy, Nucleic acid drugs

Indications:

Diseases of the nervous system / neurology

Products:
In development: 3
Description:

Crucible Therapeutics focuses on developing RNA-targeting gene therapies to address the root causes of neurodegenerative conditions, specifically Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). By utilizing RNA interference technology, the platform aims to reduce toxic proteins such as TDP-43 and dipeptide repeat proteins that drive neuronal damage, with the long-term goal of halting disease progression and offering potentially curative treatments for patients.

Curileum Discovery Ltd

Watford Road
Northwick Park & St Mark’s Hospital Campus, Y Block
Harrow, HA1 3UJ
United Kingdom

Main sector:

Biotechnology - Therapeutics and Diagnostics

Subsector:

Small molecules, Stem cells

Indications:

Neoplasms / cancer / oncology, Digestive system / gastroenterology

Products:
In development: 4
Employees:
At this location: 6
Worldwide: 6
Description:

Curileum Discovery is focused on intervening early in the development of serious gastrointestinal (GI) diseases with novel therapeutics. The company is developing a novel, oral, small molecule drug – ULI262 for bowel cancer treatment.

Cytecom Ltd.

Sir William Lyons Rd
Unit 11, The Venture Centre
Coventry, CV4 7EZ
United Kingdom

Main sector:

Biotechnology - R&D Services

Subsector:

Analytical services, Diagnostic instrumentation

Indications:

Infectious and parasitic diseases / infectiology / parasitology

Description:

Cytecom is engaged in the development of a monitoring system that detects vital bacterial populations within a sample. Based on bacterial electrophysiology, the company has developed the CyteCount, which detects bacterial cells responding electronically to an applied electric shock. The company's technology uses membrane-potential dynamics and electrical stimulation to differentiate incapacitated and viable cells, enabling medical professionals to quickly detect life-threatening microbes, potentially saving lives, and helping manufacturing companies identify contamination in their processes to ensure product safety.

Deep Blue BioTech

Arundel Street
Sheffield, S1 2NS
United Kingdom

Main sector:

Biotechnology - Other

Subsector:

Industrial Biotechnology

Description:

Deep Blue BioTech is a UK-based synthetic biology company developing sustainable biomanufacturing technologies that use engineered cyanobacteria to convert carbon dioxide (CO₂) into high-value chemicals and ingredients. Its proprietary platform combines metabolic engineering and AI-driven strain design to produce renewable molecules, including ocean-derived hyaluronic acid, with the goal of decarbonizing the chemical and personal care industries and advancing a net-zero future.

Department for Business and Trade

Admiralty Place
Old Admiralty Building
London, SW1A 2DY
United Kingdom

Main sector:

Public / Non-Profit Organizations / Medical Facilities

Subsector:

Governmental organization

Description:

TThe Department for Business and Trade (DBT) is a ministerial department of the United Kingdom government responsible for supporting businesses to invest, grow, and export, thereby creating jobs and economic opportunities.

Dia Beta Labs Ltd

4 Murray House,
Murray Street
Belfast, BT16DN
United Kingdom

Main sector:

Biotechnology - Therapeutics and Diagnostics

Subsector:

Peptides

Indications:

Endocrine, nutritional and metabolic diseases / endocrinology

Products:
In development: 3
Description:

Dia Beta Labs is a biotechnology company which is developing and commercializing pipeline of therapeutics for metabolic disease. The company is developing agents to address the progressive decline of pancreatic health in sufferers while imparting more sustainable, quality weight loss than currently available options, enabling diabetic patients with insulin-producing beta-cells. DBL001, DBL002 and DBL003 are the three therapeutic peptides through preclinical development for treatment of metabolic diseases in the company's pipeline.

Dickenson Consulting Ltd

Springfield Road
Redruthan, Oxfordshire
Wantage, OX12 8EX
United Kingdom

Main sector:

Professional Services and Consulting

Subsector:

Management consulting, Drug development consulting

Description:

Dickenson Consulting is a pharmaceutical/biopharmaceutical project management consultancy. The company specializes in outsourcing and project management solutions, particularly within drug development. Dickenson Consulting offers services ranging from identifying contractors and managing tendering to providing tailored outsourcing strategies and project management expertise, including training and mentoring.

Digostics Limited

173 Curie Avenue
Harwell Innovation Centre
Didcot, OX11 0QG
United Kingdom

Main sector:

Medical Technology

Subsector:

Diagnostic devices, Single use devices

Indications:

Pregnancy, childbirth and the puerperium / obstetrics

Description:

Digostics is dedicated to the prevention of diabetes and cardiovascular disease and to reducing the serious consequences of these conditions through an approach to home diagnostics. The wireless diagnostics platform combines disposable electronic tests, mobile apps, and the cloud to enable new services to help patients and healthcare providers work together to prevent disease.

The company's first product, is transforming the detection of diabetes by enabling the gold standard but also 'the most complex and problematic test in clinic' to be performed easily, with equivalent accuracy to the expert lab, from the home. GTT@home, allows patients to perform an oral glucose tolerance test (OGTT) conveniently at home.

Discovery Life Sciences

900 Hudson Way
Suite 1700
Huntsville, 35806
USA

Main sector:

Biotechnology - R&D Services

Subsector:

Analytical services, Diagnostic services

Indications:

Infectious and parasitic diseases / infectiology / parasitology, Neoplasms / cancer / oncology, Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology, Endocrine, nutritional and metabolic diseases / endocrinology, Cardiovascular / cardiology, Genitourinary system / Urology

Description:

Discovery Life Sciences, Inc. is the biospecimen and biomarker specialist, combining the commercial biospecimen inventory and procurement network with preeminent multi-omic biomarker service laboratories to accelerate precision medicine programs for cancer, infectious disease, and other complex conditions. The company is a provider of characterized human cellular starting materials and multi-omic analytical services to advance cell and gene therapy research, development, and manufacturing programs.

Discovery Park Limited

Ramsgate Road
Innovation House
Sandwich, CT13 9FF
United Kingdom

Main sector:

Public / Non-Profit Organizations / Medical Facilities

Subsector:

Science / Technology park

Description:

Discovery Park operates as a science park for the UK healthcare sector. The site offers a pathway in research & development, spanning from the search for new antibiotics to various research across the life sciences, including the development of new therapeutics and diagnostics to unlock the full potential of immunotherapy and immuno-oncology.

DJS Antibodies Ltd

Quarry Rd
Wood Centre for Innovation, Stansfeld Park, Headington
Oxford, OX3 8SB
United Kingdom

Main sector:

Biotechnology - Therapeutics and Diagnostics

Subsector:

Antibodies, Small molecules

Indications:

Respiratory / pulmonology, Skin and subcutaneous tissue / dermatology, Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Products:
In development: 2
Description:

DJS Antibodies designs and discovers therapeutic monoclonal antibodies against GPCRs. The company uses an HEPTAD technology to discover therapeutic antibodies against currently undruggable disease targets. The lead products in company's pipeline includes DJS 002 and DJS 001.

DLRC Ltd

The Nexus Building Broadway
Letchworth Garden City, SG6 3TA
United Kingdom

Main sector:

Professional Services and Consulting

Subsector:

Due diligence, Information provider, Market access, Drug development consulting, Reimbursement & Pricing, Regulatory Affairs

Description:

DLRC Ltd is a regulatory affairs consultancy specializing in supporting the life sciences industry. The company provides services across the full product lifecycle, including development, clinical trials, marketing authorisation, and post-marketing activities for both medicinal products and medical devices. DLRC Ltd also offers medical and scientific writing, regulatory submissions management, and business support, including due diligence and startup-focused regulatory guidance. The company serves a wide range of clients, from large pharmaceutical corporations to small and medium-sized enterprises (SMEs).

Dominion Biotech Limited

Alderley Park
Nether Alderley, SK10 4JS
United Kingdom

Main sector:

Biotechnology - R&D Services

Subsector:

CRO (Contract Research Organization)

Indications:

Neoplasms / cancer / oncology

Description:

Dominion Biotech Limited is a biotechnology company focused on accelerating drug discovery and precision oncology by utilizing patient-derived cell models (organoids) rather than animal testing. The company specializes in cancer cell analysis, offering personalized screening services and predictive oncology tools to optimize cancer treatment selection and improve clinical trial success rates.

Results 121 - 140 out of 523 displayed